ASC bio-drugs

How it works?

ASC bio-drugs are novel antibody-peptide fusion protein drugs generated by ASC technical platform. Upon entering the human body, the ASC bio-drug will be delivered to the surface of the target cancer cell. Proteases in the micro-environment of the target cancer cell will switch-on the penetrating peptide, which will create an opportunity for cytotoxic peptide payload to escape from endocytosis and then into the cancer cell to kill it.